Crinetics Pharmaceuticals Inc buy SVB Leerink LLC
Start price
29.09.25
/
50%
€38.40
Target price
29.09.26
€75.07
Performance (%)
-12.34%
Price
10.04.26
€33.66
Summary
This prediction is currently active. The prediction for Crinetics Pharmaceuticals Inc disappoints with a performance of -12.34%. This prediction currently runs until 29.09.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Crinetics Pharmaceuticals Inc | 6.519% | 6.519% |
| iShares Core DAX® | 2.554% | -0.112% |
| iShares Nasdaq 100 | 2.742% | -0.470% |
| iShares Nikkei 225® | 6.584% | 3.221% |
| iShares S&P 500 | 1.930% | -0.519% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals (NASDAQ:CRNX) had its price target raised by analysts at Leerink Partners from $80.00 to $88.00. They now have an "outperform" rating on the stock.
Ratings data for CRNX provided by MarketBeat